|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/196 | |
| A61K 31/506 | |||
| A61K 45/06 | |||
| A61P 35/02 |
| (11) | Patento numeris | 2240172 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08864891.0 |
| Europos patento paraiškos padavimo data | 2008-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-10-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-03-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/087336 |
| Data | 2008-12-18 |
| (87) | Numeris | WO 2009/082662 |
| Data | 2009-07-02 |
| (30) | Numeris | Data | Šalis |
| 15704 | 2007-12-21 | US |
| (72) |
ALOYZ, Raquel Silvia, CA
PANASCI, Lawrence Carl, CA
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |
| COMBINATION OF NILOTINIB AND CHLORAMBUCIL FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA |